tiprankstipranks
Immunocore Holdings (IMCR)
NASDAQ:IMCR
US Market

Immunocore Holdings (IMCR) Income Statement

Compare
182 Followers

Immunocore Holdings Income Statement

Last quarter (Q4 2024), Immunocore Holdings's total revenue was $84.05M, a decrease of -20.43% from the same quarter last year. In Q4, Immunocore Holdings's net income was $-23.77M. See Immunocore Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 310.20M$ 249.43M$ 143.74M$ 26.52M$ 30.11M
Gross Profit
$ 307.47M$ 248.39M$ 143.28M$ -46.71M$ -44.70M
Operating Expenses
$ 377.93M$ 308.04M$ 182.89M$ 161.68M$ 119.40M
Depreciation and Amortization
$ 0.00$ 4.09M$ 5.33M$ 7.59M$ 8.98M
EBITDA
$ -70.46M$ -51.65M$ -38.35M$ -166.72M-
Operating Income
$ -70.46M$ -59.65M$ -39.61M$ -135.16M$ -86.19M
Other Income/Expenses
$ 17.52M$ -1.24M$ 5.79M$ 33.66M$ -1.17M
Pretax Income
$ -52.94M$ -60.89M$ -44.15M$ -140.93M$ -87.36M
Net Income
$ -51.09M$ -55.29M$ -41.22M$ -131.52M$ -74.09M
Per Share Metrics
Basic EPS
$ -1.02$ -1.13$ -0.90$ -3.10$ -2.33
Diluted EPS
$ -1.02$ -1.13$ -0.90$ -3.00$ -2.33
Weighted Average Shares Outstanding
49.99M 48.89M 45.71M 42.49M 31.78M
Weighted Average Shares Outstanding (Diluted)
49.99M 48.89M 45.71M 43.86M 31.78M
Currency in USD

Immunocore Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis